Long-term follow-up of a phase 2 study of oral teriflunomide in relapsing multiple sclerosis: safety and efficacy results up to 8.5 years

Authors

Keywords

Journal

Volume 18, Issue 9, Pages 1278-1289

Publisher

SAGE Publications

Online

2012-02-04

DOI

10.1177/1352458512436594

References

View 4 related references

Discuss science. Find collaborators. Network.

Join a conversation

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started